Renaissance Technologies (RenTech)'s ANRO Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 97,399 shares of Alto Neuroscience, Inc. (ANRO) worth $1.73 M, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in ANRO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 41,072 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Alto Neuroscience (ANRO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Alto Neuroscience (ANRO) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +21,627 | Add 28.54% | 97,399 | $17.80 |
| Q3 2025 | +41,072 | Add 118.36% | 75,772 | $4.02 |
| Q2 2025 | +34,700 | New Buy | 34,700 | $2.20 |
Renaissance Technologies (RenTech)'s Alto Neuroscience Investment FAQs
Renaissance Technologies (RenTech) first purchased Alto Neuroscience, Inc. (ANRO) in Q2 2025, acquiring 34,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Alto Neuroscience, Inc. (ANRO) for 3 quarters since Q2 2025.
Renaissance Technologies (RenTech)'s largest addition to Alto Neuroscience, Inc. (ANRO) was in Q3 2025, adding 75,772 shares worth $304,603.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 97,399 shares of Alto Neuroscience, Inc. (ANRO), valued at approximately $1.73 M.
As of the Q4 2025 filing, Alto Neuroscience, Inc. (ANRO) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Alto Neuroscience, Inc. (ANRO) was 97,399 shares, as reported at the end of Q4 2025.